The EndoDNA test is the ultimate solution for personalizing your wellness journey. Our patented DNA test delivers unparalleled insights into your ideal cannabinoid and terpene profile, empowering you and your healthcare provider to make informed decisions for optimal health and well-being.
Terpene profiling to identify the most beneficial terpenes for your needs
Personalized risk assessment and individualized wellness plan
The Menopause Biotype Genetic Test is a revolutionary tool designed to inform women as they navigate the unique journey of menopause. Developed by world renown Women’s’ health specialist, Dr. Jennifer Berman. This test helps identify individual biotypes to predict menopausal symptoms, potential disease risks, and potential effective hormonal treatments and lifestyle interventions tailored to each woman’s specific needs.
The Menopause Biotype Genetic Test is a revolutionary tool designed to inform women as they navigate the unique journey of menopause. Developed by world renown Women’s’ health specialist, Dr. Jennifer Berman. This test helps identify individual biotypes to predict menopausal symptoms, potential disease risks, and potential effective hormonal treatments and lifestyle interventions tailored to each woman’s specific needs.
Personalized Insights: Understand your unique menopausal journey, including symptom severity and treatment needs.
Gain preemptive insights into potential health risks related to estrogen and/or androgen deficiencies such as osteoporosis, cardiovascular disease, and cognitive decline.
Empower healthcare providers to prescribe the most effective hormonal treatments and lifestyle adjustments, enhancing overall wellbeing and quality of life during menopause.
The transition into menopause is profoundly unique for each woman, making personalized care essential. The Metrodora Menopause Biotype Genetic Test allows you to take control of your health by understanding your genetic predispositions and the impact of lifestyle factors on your menopausal experience. Early intervention and tailored treatments can significantly improve your health outcomes.
Interested in discovering how the Metrodora Menopause Biotype Genetic Test can benefit you? Order on our website or follow the QR code below. Embrace a proactive approach to menopause with tailored, effective solutions that cater to your individual health needs.
TB006 is an experimental drug developed by TrueBinding, Inc. to treat Alzheimer’s disease. It’s a humanized monoclonal antibody that targets galectin-3, a protein that may be involved in the formation of amyloid plaques and brain inflammation, which are both associated with Alzheimer’s disease. TB006 may help improve cognition and functioning in patients with Alzheimer’s by blocking galectin-3, which could reduce neuroinflammation and the aggregation of AB and pTau proteins. Our TB006 Genetic Screening test analyzes an individual’s LGALS3 genetics to determine whether or not they are a candidate for this therapy under the FDA’s Expanded Patient Therapy program.
©2024 Endocanna Health, Inc. All rights reserved. The Endocanna Health Logo, EndoDNA, Cannabis is Personal and myDNA.live are trademarks of Endocanna Health, Inc.
